SEC 13F Intelligence

Altium Capital Management LLC / IMVT

Altium Capital Management LLC’s Immunovant Inc Position

Does Altium Capital Management LLC own Immunovant Inc (IMVT)? Not currently — the last reported position was 80.0K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2023
Shares
80.0K
% of Portfolio
+2.29%
Quarters Held
5
position exited

Position History IMVT

Reported value by quarter
Q4 ’20: $4MQ4 ’20Q1 ’21: $4MQ1 ’21Q2 ’21: $4MQ2 ’21Q2 ’23: $665,847Q2 ’23Q4 ’23: $3MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202380.0K$3M+2.29%
Q2 202335.1K$665,847+0.50%
Q2 2021335.0K$4M+0.82%
Q1 2021229.6K$4M+1.02%
Q4 202077.6K$4M+1.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of IMVT.